metformin has been researched along with Basal Ganglia Diseases in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lactic acidosis was present in 2 patients at presentation and serum lactate was elevated in 7/15 patients tested." | 1.72 | The extrapyramidal syndromes of chronic kidney disease and dialysis (EPS-CKDD): diagnostic criteria, risk factors and prognosis. ( Agarwal, A; Chemmanam, T; Irish, AB; Manickavasagar, R; Prentice, DA; Youssef, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manickavasagar, R | 1 |
| Chemmanam, T | 1 |
| Youssef, A | 1 |
| Agarwal, A | 1 |
| Prentice, DA | 1 |
| Irish, AB | 1 |
1 other study available for metformin and Basal Ganglia Diseases
| Article | Year |
|---|---|
The extrapyramidal syndromes of chronic kidney disease and dialysis (EPS-CKDD): diagnostic criteria, risk factors and prognosis.
Topics: Acidosis, Lactic; Basal Ganglia Diseases; Child, Preschool; Diabetes Mellitus, Type 2; Female; Human | 2022 |